{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:06:00Z","timestamp":1760267160690},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.autrev.2012.02.018","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T20:49:06Z","timestamp":1330462146000},"page":"837-843","source":"Crossref","is-referenced-by-count":12,"title":["B-type natriuretic peptide in rheumatic diseases: A cardiac biomarker or a sophisticated acute phase reactant?"],"prefix":"10.1016","volume":"11","author":[{"given":"Theodoros","family":"Dimitroulas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralambos","family":"Karvounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Settas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.02.018_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"de Bold","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2012.02.018_bb0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hfc.2009.04.002","article-title":"Natriuretic peptides in the diagnosis and management of chronic heart failure","volume":"5","author":"Boerrigter","year":"2009","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.autrev.2012.02.018_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3349\/ymj.2010.51.2.151","article-title":"Interpretation and use of natriuretic peptides in non-congestive heart failure settings","volume":"51","author":"Tsai","year":"2010","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0020","doi-asserted-by":"crossref","first-page":"b787","DOI":"10.1136\/bmj.b787","article-title":"Natriuretic peptides in elderly people with acute myocardial infarction","volume":"338","author":"Ribeiro","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2012.02.018_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2012.02.018_bb0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"Douglas","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients","volume":"35","author":"\u039a\u03bfh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2012.02.018_bb0050","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/00005344-199800001-00100","article-title":"Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP\/BNP production in cardiocyte culture","volume":"31","author":"Harada","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0060","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1373\/clinchem.2006.080234","article-title":"Comparison of brain natriuretic peptide (BNP) and amino-terminal proBNP for early diagnosis of heart failure","volume":"53","author":"Emdin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2012.02.018_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejheart.2003.12.012","article-title":"Use of NT-proBNP in routine testing and comparison to BNP","volume":"6","author":"Pfister","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2012.02.018_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cccn.2003.10.027","article-title":"Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease","volume":"341","author":"Mueller","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2012.02.018_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1445-5994.2007.01454.x","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0080","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3899\/jrheum.090997","article-title":"Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis","volume":"37","author":"Cavagna","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijcard.2008.11.107","article-title":"Direct comparison of B-type natriuretic peptide and N-terminal pro-BNP for assessment of cardiac function in a large population of symptomatic patients","volume":"140","author":"Park","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0090","first-page":"82","article-title":"Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher brain natriuretic peptide (BNP) levels than patients with inactive disease or healthy control subjects","volume":"79","author":"Armstrong","year":"2010","journal-title":"Ulster Med J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/ard.2006.066522","article-title":"N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?","volume":"66","author":"H\u00e4upl","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1684\/ejd.2011.1423","article-title":"N-terminal pro-brain natriuretic peptide in systemic sclerosis: new insights","volume":"21","author":"Elshamy","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0105","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10067-007-0575-4","article-title":"B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance?","volume":"26","author":"Karadag","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10067-008-0886-0","article-title":"Serum levels of natriuretic peptides in patients with Behcet's disease","volume":"27","author":"Ya\u011fci","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0115","article-title":"Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center","author":"Lee","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.104.472050","article-title":"Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis","volume":"112","author":"Brueckmann","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.018_bb0125","doi-asserted-by":"crossref","first-page":"c125","DOI":"10.1159\/000079170","article-title":"Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients","volume":"97","author":"Ortega","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.autrev.2012.02.018_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.01.001","article-title":"Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase","volume":"36","author":"Ma","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.healun.2005.09.007","article-title":"Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device","volume":"25","author":"Bruggink","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.autrev.2012.02.018_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijcard.2009.10.048","article-title":"When the heart is burning: amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease","volume":"148","author":"Giannoni","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0145","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.23796","article-title":"Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis","volume":"58","author":"Solus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0150","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2442","article-title":"The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study","volume":"10","author":"Provan","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.02.018_bb0155","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.2010.141523","article-title":"Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study","volume":"70","author":"Provan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/ard.2009.119412","article-title":"Tumour necrosis factor alpha blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10067-008-1048-0","article-title":"Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?","volume":"28","author":"Carlo-Stella","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.clinbiochem.2010.03.011","article-title":"NT-proBNP levels in systemic sclerosis: association with clinical and laboratory abnormalities","volume":"43","author":"Oravec","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2012.02.018_bb0175","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0180","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.02.018_bb0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10067-007-0724-9","article-title":"The clinical significance of serum N terminal pro-brain natriuretic peptide in systemic sclerosis patients","volume":"27","author":"Choi","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3899\/jrheum.090931","article-title":"Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction","volume":"37","author":"Dimitroulas","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0195","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1136\/ard.2008.098087","article-title":"N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?","volume":"68","author":"Allanore","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0200","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00296-009-0889-4","article-title":"Systolic and diastolic heart function in SLE patients","volume":"29","author":"Wislowska","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.02.018_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S0482-50042010000100003","article-title":"Early detection of global and regional left ventricular diastolic dysfunction in systemic lupus erythematosus: the role of the echocardiography","volume":"50","author":"Teixeira","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0210","first-page":"1314","article-title":"N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: relationship with inflammation, augmentation index, and coronary calcification","volume":"35","author":"Chung","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0220","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/acr.20425","article-title":"Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2012.02.018_bb0225","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacc.2005.10.059","article-title":"Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?","volume":"47","author":"Bhatia","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2005.040634","article-title":"Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis","volume":"65","author":"Harney","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2009.01.033","article-title":"Human coronary atherosclerosis modulates cardiac natriuretic peptide release","volume":"206","author":"Barbato","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10067-010-1622-0","article-title":"Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis","volume":"30","author":"Targo\u0144ska-St\u0119pniak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0245","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2012.02.018_bb0250","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10067-010-1494-3","article-title":"Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis","volume":"29","author":"Dimitroulas","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0255","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/keh486","article-title":"Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992\u20132001","volume":"44","author":"Hesselstrand","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2012.02.018_bb0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0265","doi-asserted-by":"crossref","first-page":"F68","DOI":"10.1016\/j.ehjsup.2004.09.010","article-title":"Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis","volume":"6","author":"Emdin","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0270","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2009.03.005","article-title":"Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension","volume":"39","author":"Dimitroulas","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0275","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10067-008-0837-9","article-title":"Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis","volume":"27","author":"Ciurzy\u0144ski","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0280","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","article-title":"Systemic sclerosis associated pulmonary hypertension: improved survival in the current era","volume":"92","author":"Williams","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.autrev.2012.02.018_bb0285","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (NT-proBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0290","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.08.070","article-title":"Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"121","author":"Dimitroulas","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0295","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10067-007-0828-2","article-title":"N-Terminal probrain natriuteric peptide as a biochemical marker in the evaluation of bosentan treatment in systemic sclerois-related pulmonary arterial hypertension","volume":"27","author":"Dimitroulas","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0300","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00296-007-0510-7","article-title":"N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH","volume":"28","author":"Simeoni","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.02.018_bb0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00296-005-0613-y","article-title":"Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports","volume":"26","author":"Hayakawa","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.02.018_bb0310","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejim.2011.02.005","article-title":"Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease","volume":"22","author":"Caravita","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2012.02.018_bb0315","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1002\/art.11345","article-title":"N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers","volume":"48","author":"Allanore","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0320","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1183\/09031936.00074309","article-title":"Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension","volume":"35","author":"Mathai","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2012.02.018_bb0325","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2012.02.018_bb0330","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2174\/138161212799504704","article-title":"Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets","volume":"18","author":"Dimitroulas","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2012.02.018_bb0335","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0340","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.autrev.2012.02.018_bb0345","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/art.27194","article-title":"Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?","volume":"62","author":"Crowson","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0350","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/ard.2009.110536","article-title":"Effect of rheumatoid factor on mortality and coronary heart disease","volume":"69","author":"Tomasson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0355","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","author":"Liang","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.02.018_bb0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2010.142133","article-title":"Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives","volume":"70","author":"Kitas","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0365","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1136\/ard.2009.127704","article-title":"NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study","volume":"69","author":"Provan","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.02.018_bb0370","first-page":"S264","article-title":"Does the Framingham Score underestimate cardiovascular risk in rheumatoid arthritis? [Abstract]","volume":"60","author":"Crowson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.018_bb0375","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/00003495-200868120-00003","article-title":"Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma","volume":"68","author":"Kabunga","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2012.02.018_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2012.2","article-title":"Imaging modalities for the pulmonary hypertension in systemic sdclerosis","author":"Dimitroulas","year":"2012","journal-title":"Nat Rev Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T21:29:44Z","timestamp":1713648584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1568997212000468"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.02.018","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}